LUNGevity Partners with ALK Positive to Award $1.5 Million in Lung Cancer Research Grants

WASHINGTON, DC (January 27, 2022) — LUNGevity Foundation is partnering for the third time with the patient-led registered nonprofit organization ALK Positive to support the ALK-Positive Lung Cancer Research Award Program. This year, the patient oncogene group will potentially fund research projects totaling up to $1.5 million over two years—their largest funding to date. The ultimate goal of the research is to transform ALK-positive lung cancer into a chronic or curable condition.

ResearchKirk SmithJanuary 27, 2022Research, Research Grants, Lungevity